How often does Regenxbio move more than the options market prices?

2 of the last 8 reports moved at least as far as the implied move.

RGNXNasdaqBiological Products, (No Diagnostic Substances)

Regenxbio Inc. (RGNX) earnings date, market-implied expected move, and options open interest by expiry

7.72

+0.09 · +1.17%

post 7.72 0.00%

After hours16:00 ETdelayed

Open7.66Volume854,955Mkt cap$503.7MEPS-3.79

Day7.54 – 7.8853%52-wk5.46 – 16.1921%

RGNX

Regenxbio Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 5

before open · in 1 day

est.Q3 FY26

Calendar

Next report

Last report

+7.43%

vs ±18.2% implied · ×0.41

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

11hQURE · customeruniQure hit with amended securities class action over Huntington's data
1dRARE · customerUltragenyx posts net loss of $118 million, revenue $173 million for Q3
1dABBV · customerAbbVie posts net earnings $4,220 million, diluted EPS $2.37 for quarter

News

Largest filed tie

13F top-10 QoQ

−0.31%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

167 managers

Top fund weight

0.22%

RGNX weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Regenxbio (RGNX) is expected to report on Nov 5 before open (estimated date).

Implied vs realized

8 reports

2 of 8≥ implied

avg implied: ±21.6%
avg realized: ±10.2%

Nov 6 '24Nov 6 '24confirmed±17.3%▲+18.66%×1.08

Mar 13 '25Mar 13 '25confirmed±17.6%▲+2.60%×0.15

May 12 '25May 12 '25confirmed±10.8%▲+2.63%×0.24

Aug 7 '25Aug 7 '25confirmed±17.3%▼−4.01%×0.23

Q3 FY25Nov 6 '25confirmed±16.9%▼−3.79%×0.22

Q1 FY26Mar 5 '26confirmed±42.1%▼−4.60%×0.11

May 14 '26May 14 '26confirmed±32.5%▼−37.80%×1.16

Q2 FY26Aug 6 '26confirmed±18.2%▲+7.43%×0.41

quarterimplied−45%0+45%realized×

Q2 FY26±18.2%▲+7.43%×0.41

May '26±32.5%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Oct 30 close

0.14OI · 4 expiries · Oct 30 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1950%Nov 2016d1,3960%

30%Dec 1844d0.01300+168%0.01

9920%Jan 1572d0.293,4560%0.29

4720%Apr 16163d0.311,5260%0.31

ExpiryPutsCallsP/C

Nov 2016d1950%1,3960%0.14

Dec 1844d30%300+168%0.01

Jan 1572d9920%3,4560%0.29

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

21.02%as filednet margin · revenue +1589.64% QoQ · +405.73% YoY

Revenue$108M+1589.64%

Gross profit$108M100.00%+1589.64%

Operating income$29M27.09%+135.10%

Pre-tax income$23M+125.22%

Net income$23M21.02%+125.22%

Cost of revenue$0—

Operating expenses$79M−12.25%

Other expense−$7M+2.02%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×1.44· ±5.3% vs ±3.7% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±5.3%12 of 24×1.44

GDPgross domestic product±3.7%14 of 20×0.99

CPROFcorporate profits±3.4%9 of 12×0.93

NFPjobs report±3.2%4 of 10×0.86

PCEpersonal income & outlays±3.0%12 of 20×0.83

CPIconsumer prices±2.8%3 of 11×0.76

PPIproducer prices±2.5%4 of 11×0.69

Bar = avg |move| to ±6% · tick = ±3.7% avg day · ×base = |move| ÷ ±3.7% · min 6 releases

Earnings history

EPS 0.43 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	0.43	—
Q1 FY26	Mar 5 '26 · confirmed	-1.72	—
Q3 FY25	Nov 6 '25 · confirmed	-1.20	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod